UNITED KINGDOM – Pharmaceutical and healthcare giant GlaxoSmithKline (GSK) has opened a new aseptic smart manufacturing facility at its Barnard Castle site, representing an investment of more than £90 million…
Read MoreTag: GSK
GSK unveils new branding and logo
UNITED KINGDOM – Pharmaceutical company GSK has revealed a rebrand, as it refocuses its efforts in the area of “biopharma innovation.” London-based consultancy Wolff Olins is behind the new look,…
Read MoreUS FDA approves GSK’s measles vaccine
USA – US Food and Drug administration (US FDA) has approved GSK’s Priorix (Measles, Mumps, and Rubella Vaccine Live) for individuals at least 1 year old. MMR vaccines are recommended…
Read MorePfizer to sell stake in GSK consumer health joint venture after spinoff
UNITED KINGDOM – Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the business lists as an independent company in July,…
Read MoreViiV pledges to license its patents on long-acting cabotegravir for HIV pre-exposure prophylaxis
SWITZERLAND – GlaxoSmithKline’s ViiV Healthcare has committed to grant voluntary license on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations, where…
Read MoreGSK to buy Affinivax in US$3.3 billion deal, expands vaccine portfolio
UNITED KINGDOM – GSK has announced a definitive agreement to acquire Affinivax for up to US$3.3 billion, including a US$2.1 billion upfront payment, with potential milestone payments of up to…
Read MoreGSK to open a new distribution hub in South America
URUGUAY – GlaxoSmithKline (GSK) announced the opening of one of its “three new regional vaccine distribution centers” in Uruguay during President Luis Lacalle Pou’s visit to London. In the next…
Read MoreFDA accepts New Drug Application for GSK’s anemia treatment
USA –GSK announced that the US Food and Drug Administration has approved a new drug application for daprodustat for people with chronic kidney disease (CKD) who also have anemia. GSK…
Read MoreGSK to buy Sierra Oncology for US$1.9 billion to boost drug pipeline
UNITED KINGDOM – GlaxoSmithKline (GSK) sought to strengthen its cancer business on Wednesday by agreeing to a US$1.9 billion deal to acquire US drug developer Sierra Oncology, the latest move…
Read MoreGSK, CureVac and BioNTech awarded German pandemic preparedness contracts
GERMANY –CureVac and GlaxoSmithKline have signed on to a German pandemic contingency plan to reserve mRNA production capacity for years to come as they take another stab at a second-generation…
Read More